Pharmacokinetic study of human complement factor H antibody GT103 in mice period of performance: 5/15/2018 - 12/31/18 task order type: firm fixed price
Ended Awarded Last action
- Contract number
- 75N91018F00002
- Awardee
-
Southern Research Institute UEI CDZJAJJHJMH5
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $15,971
Award facts
- Opportunity
-
- N02CM4700142 Solicitation number
- Preclinical toxicology of drugs developed for cancer patients Award Notice · Posted Apr 4, 2014
- Contract value 100% obligated
- $15,971.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541690 Other Scientific and Technical Consulting Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Birmingham, AL 35255, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract 75N91018F00002?
75N91018F00002 was awarded to Southern Research Institute by National Cancer Institute (National Institutes of Health) on May 21, 2018.
How much is contract 75N91018F00002 worth?
The government has obligated $15,971 on 75N91018F00002.
Is contract 75N91018F00002 an order under another contract?
Yes. 75N91018F00002 is a delivery order under HHSN261201600018I, an indefinite delivery contract, on Toxicology of Drugs Developed for Cancer Patients.
Was contract 75N91018F00002 competed?
The extent of competition for 75N91018F00002 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award